Key result
Various therapeutic strategies to detoxify endotoxins during cardiac surgery with cardiopulmonary bypass have not shown significant differences in clinical outcomes.
Why the study?
Do therapeutic strategies to detoxify endotoxins improve clinical outcomes in patients undergoing cardiac surgery with cardiopulmonary bypass?
Do therapeutic strategies to detoxify endotoxins improve clinical outcomes in patients undergoing cardiac surgery with cardiopulmonary bypass?
Despite various strategies to detoxify endotoxins during cardiopulmonary bypass, none have demonstrated a statistically significant improvement in clinical outcomes.
Answers are grounded in this paper and cite their sources.
Endotoxin detoxification lacks proven benefit during CPB; leaves open whether targeted strategies merit prospective RCTs.
Cardiac surgery with cardiopulmonary bypass provokes a systemic inflammatory response syndrome caused by the surgical trauma itself, blood contact with the non-physiological surfaces of the extracorporeal circuit, endotoxemia, and ischemia. The role of endotoxin in the inflammatory response syndrome has been well investigated. In this report, we reviewed recent advances in the understanding of the pathophysiology of the endotoxin release during cardiopulmonary bypass and the possible therapeutic strategies aimed to reduce the endotoxin release or to counteract the inflammatory effects of endotoxin. Although many different strategies to detoxify endotoxins were evaluated, none of them were able to show statistically significant differences in clinical outcome.
No takes yet. Share an insight, caveat, or question.
Kats et al. (2010) conducted a review in Cardiac surgery with cardiopulmonary bypass. Strategies to detoxify endotoxins was evaluated on Clinical outcome. Various therapeutic strategies to detoxify endotoxins during cardiac surgery with cardiopulmonary bypass have not shown significant differences in clinical outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: